A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -31.23% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -5.01%. Over the past 30 days, the price of CAPR has leaped by -38.30%. And in the last five days, it has fallen by -28.54%.
Capricor Therapeutics Inc ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $23.40 on 10/15/24, while the lowest value for the same period was recorded at $3.52 on 08/07/24.
52-week price history of CAPR Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Capricor Therapeutics Inc’s current trading price is -59.44% away from its 52-week high, while its distance from the 52-week low is 169.60%. The stock’s price range during this period has varied between$3.52 and $23.40. The Capricor Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 3.37 million for the day, a figure considerably higher than their average daily volume of 1.16 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Capricor Therapeutics Inc (CAPR) has experienced a quarterly decline of -32.60% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 433.47M and boasts a workforce of 160 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 14.86, with a change in price of -9.96. Similarly, Capricor Therapeutics Inc recorded 1,289,601 in trading volume during the last 100 days, posting a change of -51.21%.
CAPR’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CAPR stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.03.
CAPR Stock Stochastic Average
Capricor Therapeutics Inc’s raw stochastic average for the past 50 days is presently 6.44%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 6.70%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 7.13% and 17.13%, respectively.
